New injector tested for arthritis drug in healthy volunteers
NCT ID NCT07007091
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested how well risankizumab enters the body when given through an on-body injector compared to a standard prefilled syringe. 260 healthy volunteers received the drug by one of the two methods. Researchers measured drug levels in the blood and checked for side effects to see if the injector works as well as the syringe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Risankizumab
What this could lead to
If successful, this could lead to a more convenient way to give risankizumab using an on-body injector instead of a syringe.
What could go wrong
This is an early-phase study in healthy people, not patients. It only checks how the drug moves through the body and basic safety, not whether it works for any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 276043
Grayslake, Illinois, 60030, United States
-
Cpmi /Id# 276490
Miami, Florida, 33172, United States
-
PPD Phase I Clinic /ID# 276525
Austin, Texas, 78744, United States
-
Ppd - Las Vegas Research Unit /ID# 276565
Las Vegas, Nevada, 89113, United States